S. Ahn, J. Kao, P. Lampertico, A. Ramji, S. Fung, W. Chuang, Y. Kim, Chi-yi Chen, E. Tam, H. Bae, Xiaoli Ma, June-Sung Lee, Carol Yee Kwan Chan, L. Yee, S. Sethi, J. Flaherty, Yang Zhao, A. Gaggar, H. Hann, Y. Lim, H. Chan
{"title":"在病毒学抑制的亚洲乙肝患者中,富马酸替诺福韦二氧吡酯(TDF)转替诺福韦α胺(TAF)与继续TDF治疗的96周疗效和安全性比较","authors":"S. Ahn, J. Kao, P. Lampertico, A. Ramji, S. Fung, W. Chuang, Y. Kim, Chi-yi Chen, E. Tam, H. Bae, Xiaoli Ma, June-Sung Lee, Carol Yee Kwan Chan, L. Yee, S. Sethi, J. Flaherty, Yang Zhao, A. Gaggar, H. Hann, Y. Lim, H. Chan","doi":"10.1136/gutjnl-2021-iddf.82","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"IDDF2021-ABS-0080 96-week efficacy and safety of tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) switch vs. continued TDF treatment among virologically-suppressed hepatitis B patients of asian ethnicity\",\"authors\":\"S. Ahn, J. Kao, P. Lampertico, A. Ramji, S. Fung, W. Chuang, Y. Kim, Chi-yi Chen, E. Tam, H. Bae, Xiaoli Ma, June-Sung Lee, Carol Yee Kwan Chan, L. Yee, S. Sethi, J. Flaherty, Yang Zhao, A. Gaggar, H. Hann, Y. Lim, H. Chan\",\"doi\":\"10.1136/gutjnl-2021-iddf.82\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9921,\"journal\":{\"name\":\"Chinese Journal of Clinical Hepatology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chinese Journal of Clinical Hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/gutjnl-2021-iddf.82\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Clinical Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/gutjnl-2021-iddf.82","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
IDDF2021-ABS-0080 96-week efficacy and safety of tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) switch vs. continued TDF treatment among virologically-suppressed hepatitis B patients of asian ethnicity